Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiography, Interventional | 8 | 2019 | 1114 | 2.010 |
Why?
|
Lung | 34 | 2024 | 9994 | 1.800 |
Why?
|
Tomography, X-Ray Computed | 52 | 2024 | 20509 | 1.610 |
Why?
|
Lung Neoplasms | 36 | 2024 | 13262 | 1.590 |
Why?
|
Lung Diseases, Interstitial | 10 | 2024 | 911 | 1.360 |
Why?
|
Biopsy, Needle | 6 | 2021 | 1630 | 1.110 |
Why?
|
Radiography, Thoracic | 15 | 2021 | 1296 | 1.090 |
Why?
|
Multiple Pulmonary Nodules | 3 | 2019 | 167 | 1.050 |
Why?
|
Hemoptysis | 5 | 2019 | 152 | 0.860 |
Why?
|
Cryosurgery | 4 | 2023 | 475 | 0.840 |
Why?
|
Lung Diseases | 7 | 2021 | 1915 | 0.760 |
Why?
|
Bronchiectasis | 1 | 2022 | 139 | 0.750 |
Why?
|
Idiopathic Pulmonary Fibrosis | 6 | 2024 | 502 | 0.740 |
Why?
|
Catheter Ablation | 9 | 2022 | 2758 | 0.720 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2019 | 277 | 0.550 |
Why?
|
Fiducial Markers | 1 | 2017 | 132 | 0.510 |
Why?
|
Thoracic Diseases | 2 | 2012 | 99 | 0.510 |
Why?
|
Dyspnea | 4 | 2021 | 1352 | 0.500 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 8 | 2023 | 5251 | 0.500 |
Why?
|
Pneumothorax | 5 | 2022 | 379 | 0.490 |
Why?
|
Cough | 2 | 2020 | 595 | 0.480 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2017 | 270 | 0.450 |
Why?
|
Tomography, Optical Coherence | 6 | 2024 | 2884 | 0.420 |
Why?
|
Microwaves | 2 | 2022 | 185 | 0.420 |
Why?
|
Lymphatic Diseases | 2 | 2012 | 319 | 0.400 |
Why?
|
Radiation Dosage | 7 | 2021 | 1958 | 0.400 |
Why?
|
Respiratory Tract Infections | 1 | 2019 | 1007 | 0.370 |
Why?
|
Positron-Emission Tomography | 4 | 2018 | 6465 | 0.360 |
Why?
|
Tuberous Sclerosis | 3 | 2013 | 1030 | 0.340 |
Why?
|
Bronchoscopy | 3 | 2024 | 911 | 0.320 |
Why?
|
Diagnosis, Differential | 20 | 2022 | 12965 | 0.320 |
Why?
|
Preoperative Care | 1 | 2017 | 2256 | 0.300 |
Why?
|
Tracheal Diseases | 1 | 2009 | 115 | 0.300 |
Why?
|
Lung Diseases, Parasitic | 1 | 2007 | 14 | 0.300 |
Why?
|
Fluorodeoxyglucose F18 | 4 | 2013 | 2007 | 0.280 |
Why?
|
Early Detection of Cancer | 5 | 2024 | 3202 | 0.280 |
Why?
|
Middle Aged | 56 | 2024 | 220352 | 0.280 |
Why?
|
Babesiosis | 1 | 2007 | 92 | 0.270 |
Why?
|
Fibrosis | 2 | 2024 | 2042 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2021 | 3205 | 0.260 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 5 | 2017 | 1215 | 0.250 |
Why?
|
Radiopharmaceuticals | 3 | 2013 | 2634 | 0.250 |
Why?
|
Retrospective Studies | 30 | 2024 | 80372 | 0.250 |
Why?
|
Hemorrhage | 2 | 2015 | 3600 | 0.250 |
Why?
|
Humans | 101 | 2024 | 760621 | 0.250 |
Why?
|
Hypertension, Pulmonary | 2 | 2015 | 1570 | 0.250 |
Why?
|
Aged | 42 | 2024 | 169152 | 0.230 |
Why?
|
Sensitivity and Specificity | 8 | 2019 | 14660 | 0.230 |
Why?
|
Thoracic Neoplasms | 2 | 2004 | 266 | 0.230 |
Why?
|
Radiographic Image Enhancement | 3 | 2018 | 875 | 0.230 |
Why?
|
Contrast Media | 9 | 2024 | 5305 | 0.230 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 2023 | 45 | 0.220 |
Why?
|
Airway Obstruction | 1 | 2009 | 662 | 0.220 |
Why?
|
Male | 66 | 2024 | 359744 | 0.220 |
Why?
|
Retroperitoneal Fibrosis | 2 | 2024 | 42 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.210 |
Why?
|
Chest Tubes | 2 | 2019 | 152 | 0.210 |
Why?
|
Biopsy, Fine-Needle | 2 | 2019 | 1110 | 0.200 |
Why?
|
Female | 57 | 2024 | 391270 | 0.200 |
Why?
|
Pulmonary Fibrosis | 3 | 2018 | 506 | 0.200 |
Why?
|
Aged, 80 and over | 20 | 2021 | 58995 | 0.200 |
Why?
|
Iopamidol | 5 | 2014 | 186 | 0.200 |
Why?
|
Biopsy | 7 | 2022 | 6771 | 0.190 |
Why?
|
Cryptogenic Organizing Pneumonia | 1 | 2021 | 28 | 0.190 |
Why?
|
AIDS-Related Opportunistic Infections | 3 | 2012 | 662 | 0.190 |
Why?
|
Hemosiderosis | 1 | 2021 | 66 | 0.190 |
Why?
|
Glomerulonephritis, IGA | 1 | 2021 | 62 | 0.190 |
Why?
|
Lymph Nodes | 2 | 2022 | 3486 | 0.180 |
Why?
|
Neuroendocrine Cells | 1 | 2021 | 62 | 0.180 |
Why?
|
Delphi Technique | 1 | 2023 | 829 | 0.180 |
Why?
|
Hemothorax | 1 | 2019 | 57 | 0.170 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2023 | 225 | 0.170 |
Why?
|
Influenza, Human | 3 | 2021 | 1528 | 0.160 |
Why?
|
Prednisone | 2 | 2021 | 1565 | 0.150 |
Why?
|
Thoracic Wall | 1 | 2019 | 199 | 0.150 |
Why?
|
Glucocorticoids | 3 | 2024 | 2145 | 0.150 |
Why?
|
Neuroendocrine Tumors | 1 | 2024 | 650 | 0.150 |
Why?
|
Feasibility Studies | 2 | 2019 | 5201 | 0.150 |
Why?
|
Embolism, Air | 1 | 2017 | 110 | 0.140 |
Why?
|
Observer Variation | 6 | 2021 | 2601 | 0.140 |
Why?
|
Ribonucleoproteins | 1 | 2019 | 372 | 0.140 |
Why?
|
Wireless Technology | 1 | 2017 | 98 | 0.140 |
Why?
|
Consensus | 2 | 2023 | 3113 | 0.140 |
Why?
|
Lymphatic Metastasis | 1 | 2004 | 2943 | 0.130 |
Why?
|
Phenotype | 2 | 2024 | 16546 | 0.130 |
Why?
|
Calcinosis | 2 | 2021 | 1476 | 0.130 |
Why?
|
Temporal Arteries | 1 | 2017 | 148 | 0.130 |
Why?
|
Pulmonary Eosinophilia | 1 | 2016 | 78 | 0.130 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2018 | 9276 | 0.120 |
Why?
|
Pulmonary Embolism | 2 | 2010 | 2543 | 0.120 |
Why?
|
Fever | 5 | 2016 | 1617 | 0.120 |
Why?
|
Reproducibility of Results | 7 | 2021 | 20080 | 0.120 |
Why?
|
Tomography, Emission-Computed | 2 | 2011 | 1121 | 0.120 |
Why?
|
Pulmonary Artery | 2 | 2016 | 1921 | 0.120 |
Why?
|
Vasculitis | 2 | 2017 | 523 | 0.120 |
Why?
|
Preoperative Period | 1 | 2017 | 555 | 0.120 |
Why?
|
Hyperplasia | 2 | 2021 | 1155 | 0.120 |
Why?
|
Practice Guidelines as Topic | 3 | 2021 | 7475 | 0.120 |
Why?
|
Neoplasm Staging | 7 | 2018 | 11152 | 0.120 |
Why?
|
Organometallic Compounds | 1 | 2018 | 662 | 0.120 |
Why?
|
Adult | 30 | 2024 | 219994 | 0.110 |
Why?
|
Aneurysm, False | 1 | 2016 | 257 | 0.110 |
Why?
|
Heart Arrest | 1 | 2004 | 1506 | 0.110 |
Why?
|
Precancerous Conditions | 1 | 2021 | 977 | 0.110 |
Why?
|
Bronchoalveolar Lavage | 1 | 2014 | 129 | 0.110 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 2 | 2023 | 288 | 0.110 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2019 | 8950 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 983 | 0.110 |
Why?
|
Gadolinium | 1 | 2018 | 959 | 0.110 |
Why?
|
Thymus Neoplasms | 1 | 2015 | 274 | 0.110 |
Why?
|
Mediastinal Neoplasms | 1 | 2015 | 402 | 0.100 |
Why?
|
Immunoglobulin G | 3 | 2024 | 4541 | 0.100 |
Why?
|
Radiography | 8 | 2011 | 6965 | 0.100 |
Why?
|
Immune Reconstitution Inflammatory Syndrome | 1 | 2012 | 61 | 0.100 |
Why?
|
Diagnostic Imaging | 4 | 2024 | 3527 | 0.100 |
Why?
|
Ferric Compounds | 1 | 2013 | 377 | 0.100 |
Why?
|
Breast Diseases | 1 | 2015 | 443 | 0.100 |
Why?
|
Chi-Square Distribution | 3 | 2013 | 3465 | 0.100 |
Why?
|
Geriatric Assessment | 1 | 2019 | 1405 | 0.100 |
Why?
|
Mediastinum | 2 | 2004 | 266 | 0.090 |
Why?
|
Point-of-Care Systems | 2 | 2017 | 1204 | 0.090 |
Why?
|
Pleural Effusion | 1 | 2014 | 342 | 0.090 |
Why?
|
Pulmonary Infarction | 1 | 2010 | 11 | 0.090 |
Why?
|
Autoantibodies | 1 | 2019 | 2118 | 0.090 |
Why?
|
Radiology | 2 | 2022 | 2102 | 0.090 |
Why?
|
Respiratory Function Tests | 2 | 2012 | 1683 | 0.090 |
Why?
|
Lymphangitis | 1 | 2010 | 15 | 0.090 |
Why?
|
Hermanski-Pudlak Syndrome | 1 | 2009 | 20 | 0.090 |
Why?
|
Bronchial Fistula | 1 | 2010 | 83 | 0.090 |
Why?
|
Incidental Findings | 1 | 2015 | 698 | 0.080 |
Why?
|
Neoplasm Metastasis | 2 | 2019 | 4902 | 0.080 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1998 | 2197 | 0.080 |
Why?
|
Vascular Diseases | 1 | 2018 | 1182 | 0.080 |
Why?
|
Patient Selection | 2 | 2012 | 4283 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2018 | 1588 | 0.080 |
Why?
|
Pleural Diseases | 1 | 2010 | 137 | 0.080 |
Why?
|
Disease Progression | 3 | 2019 | 13502 | 0.080 |
Why?
|
Anticoagulants | 1 | 2004 | 4897 | 0.080 |
Why?
|
Skin Diseases | 1 | 2017 | 1089 | 0.080 |
Why?
|
Papilloma | 1 | 2009 | 141 | 0.080 |
Why?
|
Mediastinal Diseases | 1 | 2008 | 91 | 0.080 |
Why?
|
Tracheal Neoplasms | 1 | 2009 | 123 | 0.080 |
Why?
|
Conscious Sedation | 1 | 2012 | 529 | 0.070 |
Why?
|
Thymus Gland | 1 | 2013 | 1247 | 0.070 |
Why?
|
Oseltamivir | 1 | 2008 | 76 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2290 | 0.070 |
Why?
|
Intensive Care Units | 2 | 2019 | 3736 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2803 | 0.070 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2009 | 203 | 0.070 |
Why?
|
Antiprotozoal Agents | 1 | 2007 | 94 | 0.070 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2013 | 938 | 0.070 |
Why?
|
Cohort Studies | 7 | 2023 | 41335 | 0.070 |
Why?
|
Tracheal Stenosis | 1 | 2009 | 226 | 0.070 |
Why?
|
Rare Diseases | 1 | 2012 | 619 | 0.070 |
Why?
|
Positive-Pressure Respiration | 1 | 2010 | 636 | 0.070 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2009 | 448 | 0.060 |
Why?
|
Vascular Neoplasms | 1 | 2007 | 167 | 0.060 |
Why?
|
Carcinoma | 2 | 2010 | 2331 | 0.060 |
Why?
|
Radiosurgery | 1 | 2015 | 1343 | 0.060 |
Why?
|
Treatment Outcome | 9 | 2021 | 65017 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2012 | 2362 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2022 | 4775 | 0.060 |
Why?
|
Anti-Bacterial Agents | 2 | 2022 | 7408 | 0.060 |
Why?
|
Acute Disease | 1 | 2015 | 7269 | 0.060 |
Why?
|
Mediastinitis | 1 | 2024 | 49 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 4 | 2018 | 36290 | 0.060 |
Why?
|
Postoperative Complications | 3 | 2013 | 15697 | 0.060 |
Why?
|
Pneumonectomy | 1 | 2011 | 1111 | 0.060 |
Why?
|
Pneumonia | 3 | 2010 | 2131 | 0.060 |
Why?
|
Amyloidosis | 1 | 2010 | 817 | 0.060 |
Why?
|
Iohexol | 1 | 2024 | 204 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5889 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2013 | 3765 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 2 | 2013 | 2802 | 0.050 |
Why?
|
Trachea | 1 | 2009 | 1082 | 0.050 |
Why?
|
Societies, Medical | 3 | 2021 | 3905 | 0.050 |
Why?
|
Prevalence | 1 | 2019 | 15687 | 0.050 |
Why?
|
Artifacts | 3 | 2019 | 1898 | 0.050 |
Why?
|
Nanoparticles | 1 | 2013 | 1943 | 0.050 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 2 | 2015 | 494 | 0.050 |
Why?
|
Fractures, Bone | 2 | 2004 | 2041 | 0.050 |
Why?
|
Lymphoma | 2 | 2015 | 1898 | 0.050 |
Why?
|
Lymphoma, B-Cell | 1 | 2007 | 935 | 0.050 |
Why?
|
Myocardium | 1 | 2013 | 4700 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8624 | 0.040 |
Why?
|
Young Adult | 8 | 2022 | 58741 | 0.040 |
Why?
|
Pilot Projects | 4 | 2018 | 8555 | 0.040 |
Why?
|
Anesthesia | 1 | 2011 | 1584 | 0.040 |
Why?
|
Rotation | 1 | 2021 | 514 | 0.040 |
Why?
|
Ankle Injuries | 1 | 2004 | 334 | 0.040 |
Why?
|
Program Evaluation | 2 | 2020 | 2493 | 0.040 |
Why?
|
Peroxidase | 1 | 2023 | 605 | 0.040 |
Why?
|
Prospective Studies | 8 | 2021 | 54303 | 0.040 |
Why?
|
Punctures | 1 | 2001 | 370 | 0.040 |
Why?
|
Pleura | 1 | 2001 | 244 | 0.040 |
Why?
|
Algorithms | 3 | 2018 | 13981 | 0.040 |
Why?
|
Pleural Neoplasms | 1 | 2004 | 609 | 0.040 |
Why?
|
Workflow | 1 | 2024 | 852 | 0.040 |
Why?
|
Protozoan Infections | 1 | 1998 | 39 | 0.040 |
Why?
|
Lung Transplantation | 1 | 2008 | 1305 | 0.040 |
Why?
|
Physical Exertion | 1 | 2021 | 662 | 0.040 |
Why?
|
Retroperitoneal Space | 1 | 2018 | 173 | 0.040 |
Why?
|
Clinical Protocols | 1 | 2024 | 1440 | 0.040 |
Why?
|
Workload | 1 | 2024 | 847 | 0.040 |
Why?
|
Massachusetts | 2 | 2021 | 8803 | 0.040 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2010 | 2159 | 0.040 |
Why?
|
Lung Diseases, Fungal | 1 | 1998 | 126 | 0.040 |
Why?
|
Mesothelioma | 1 | 2004 | 807 | 0.040 |
Why?
|
Risk Factors | 3 | 2022 | 74359 | 0.040 |
Why?
|
Organizational Innovation | 1 | 2020 | 536 | 0.040 |
Why?
|
Fluoroscopy | 1 | 2021 | 948 | 0.040 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2007 | 1403 | 0.040 |
Why?
|
Referral and Consultation | 2 | 2024 | 3598 | 0.040 |
Why?
|
Hypergammaglobulinemia | 1 | 2017 | 72 | 0.040 |
Why?
|
Iodine | 1 | 2019 | 286 | 0.040 |
Why?
|
Acute Kidney Injury | 2 | 2009 | 1941 | 0.030 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2004 | 1004 | 0.030 |
Why?
|
Sweating | 1 | 2017 | 154 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 2 | 2012 | 2569 | 0.030 |
Why?
|
HIV Infections | 2 | 2012 | 17165 | 0.030 |
Why?
|
Alveolitis, Extrinsic Allergic | 1 | 2016 | 62 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2013 | 2852 | 0.030 |
Why?
|
Antiviral Agents | 1 | 2008 | 3061 | 0.030 |
Why?
|
Accidental Falls | 1 | 2003 | 1056 | 0.030 |
Why?
|
Quality Improvement | 2 | 2024 | 3836 | 0.030 |
Why?
|
Reference Standards | 1 | 2018 | 1004 | 0.030 |
Why?
|
Venous Thrombosis | 1 | 2004 | 1299 | 0.030 |
Why?
|
Area Under Curve | 1 | 2018 | 1636 | 0.030 |
Why?
|
Suicide, Attempted | 1 | 2003 | 1378 | 0.030 |
Why?
|
Program Development | 1 | 2020 | 1297 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2004 | 2167 | 0.030 |
Why?
|
Bronchi | 1 | 2018 | 848 | 0.030 |
Why?
|
Outpatients | 1 | 2022 | 1607 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15289 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2024 | 22053 | 0.030 |
Why?
|
Esophageal Neoplasms | 1 | 2004 | 1648 | 0.030 |
Why?
|
Rheumatology | 1 | 2019 | 611 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2022 | 2180 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2722 | 0.030 |
Why?
|
Click Chemistry | 1 | 2013 | 95 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2009 | 4024 | 0.030 |
Why?
|
Prescriptions | 1 | 2015 | 388 | 0.030 |
Why?
|
Smoking | 2 | 2023 | 9073 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3441 | 0.030 |
Why?
|
Cerebral Hemorrhage | 1 | 2004 | 2660 | 0.030 |
Why?
|
Adolescent | 4 | 2015 | 87810 | 0.030 |
Why?
|
Testicular Neoplasms | 1 | 1998 | 801 | 0.030 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2015 | 385 | 0.020 |
Why?
|
Patient Admission | 1 | 2019 | 1386 | 0.020 |
Why?
|
Body Fat Distribution | 1 | 2013 | 243 | 0.020 |
Why?
|
Angiomyolipoma | 1 | 2013 | 184 | 0.020 |
Why?
|
Abdominal Neoplasms | 1 | 2013 | 286 | 0.020 |
Why?
|
Echocardiography | 1 | 2004 | 4981 | 0.020 |
Why?
|
Mutation | 3 | 2013 | 29932 | 0.020 |
Why?
|
Genes, erbB-1 | 1 | 2011 | 160 | 0.020 |
Why?
|
Respiratory Insufficiency | 2 | 2009 | 1231 | 0.020 |
Why?
|
Electrocardiography | 1 | 2004 | 6414 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3568 | 0.020 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2022 | 1459 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2014 | 1578 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2011 | 8986 | 0.020 |
Why?
|
Bacterial Infections | 1 | 1998 | 1403 | 0.020 |
Why?
|
Cadaver | 1 | 2014 | 1345 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2009 | 66 | 0.020 |
Why?
|
Patient Compliance | 1 | 2020 | 2688 | 0.020 |
Why?
|
Medical Records | 1 | 2015 | 1407 | 0.020 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2010 | 55 | 0.020 |
Why?
|
Recurrence | 2 | 2016 | 8482 | 0.020 |
Why?
|
Heart Neoplasms | 1 | 2013 | 360 | 0.020 |
Why?
|
Tick-Borne Diseases | 1 | 2009 | 36 | 0.020 |
Why?
|
Fatigue | 1 | 2017 | 1544 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2002 | 2471 | 0.020 |
Why?
|
Chronic Disease | 2 | 2016 | 9287 | 0.020 |
Why?
|
Headache | 1 | 2017 | 1249 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 2009 | 379 | 0.020 |
Why?
|
Antiphospholipid Syndrome | 1 | 2010 | 165 | 0.020 |
Why?
|
Scapula | 1 | 2010 | 173 | 0.020 |
Why?
|
Puerto Rico | 1 | 2009 | 373 | 0.020 |
Why?
|
Risk Assessment | 3 | 2018 | 24123 | 0.020 |
Why?
|
Research | 1 | 2015 | 1974 | 0.020 |
Why?
|
United States | 3 | 2021 | 72461 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2008 | 437 | 0.020 |
Why?
|
Kidney | 1 | 2022 | 7064 | 0.020 |
Why?
|
Forecasting | 1 | 2015 | 2932 | 0.020 |
Why?
|
Optic Neuritis | 1 | 2008 | 174 | 0.020 |
Why?
|
Urinalysis | 1 | 2008 | 368 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2018 | 2250 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 15757 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2015 | 1164 | 0.020 |
Why?
|
Community-Acquired Infections | 1 | 2009 | 461 | 0.020 |
Why?
|
Weight Loss | 1 | 2017 | 2686 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2315 | 0.020 |
Why?
|
Palliative Care | 2 | 2010 | 3607 | 0.020 |
Why?
|
Quinazolines | 1 | 2011 | 1363 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2009 | 1832 | 0.020 |
Why?
|
Vincristine | 1 | 2007 | 1039 | 0.020 |
Why?
|
Brain | 1 | 2011 | 26951 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4048 | 0.010 |
Why?
|
Hypotension | 1 | 2010 | 883 | 0.010 |
Why?
|
Mass Screening | 1 | 2020 | 5423 | 0.010 |
Why?
|
Arthralgia | 1 | 2008 | 461 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2013 | 6238 | 0.010 |
Why?
|
Duodenum | 1 | 2007 | 486 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39261 | 0.010 |
Why?
|
Bacteremia | 1 | 2010 | 980 | 0.010 |
Why?
|
Combined Modality Therapy | 2 | 2010 | 8552 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2013 | 2629 | 0.010 |
Why?
|
Survival Analysis | 1 | 2015 | 10182 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2011 | 2418 | 0.010 |
Why?
|
Rib Fractures | 1 | 2003 | 128 | 0.010 |
Why?
|
Health Personnel | 1 | 2015 | 3310 | 0.010 |
Why?
|
Skull Fractures | 1 | 2003 | 202 | 0.010 |
Why?
|
Decision Making | 1 | 2015 | 3925 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2007 | 2221 | 0.010 |
Why?
|
Leg Injuries | 1 | 2003 | 178 | 0.010 |
Why?
|
Renal Insufficiency | 1 | 2007 | 820 | 0.010 |
Why?
|
Trauma Severity Indices | 1 | 2003 | 478 | 0.010 |
Why?
|
Chest Pain | 1 | 2008 | 1106 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2007 | 1268 | 0.010 |
Why?
|
Doxorubicin | 1 | 2007 | 2209 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2009 | 4107 | 0.010 |
Why?
|
Heart | 1 | 2013 | 4393 | 0.010 |
Why?
|
Registries | 1 | 2015 | 8469 | 0.010 |
Why?
|
Pelvis | 1 | 2003 | 743 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2010 | 2532 | 0.010 |
Why?
|
Spinal Fractures | 1 | 2003 | 702 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2004 | 21025 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 11712 | 0.000 |
Why?
|
Time Factors | 1 | 2001 | 40165 | 0.000 |
Why?
|